Exclusive

Publication

Byline

Singapore Clinical Trial: IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507) versus Platinum-based Chemotherapy in Patients with EGFR-mutated Non-small Cell Lung Cancer and Disease Progression on EGFR Tyrosine Kinase Inhibitor Therapy.

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'IZABRIGHT-Lung01: A Randomized, Open-label, Phase 2/3 Study of Izalontamab Brengitecan (BMS-986507)... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More


Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherap... Read More


Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety... Read More


Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy Versus Physician’s Choice of Chemotherapy in Participants With B7-H4-selected Advanced/Metastatic Endometrial Cancer Who Progressed on or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, Nov. 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Mo... Read More


Johari Ghani: Some firms still pay TVET graduates like foreign workers despite minimum wage increase

KUALA LUMPUR, Nov. 1 -- Some Malaysian firms remain reluctant to pay local vocational graduates decent wages, often offering them salaries equivalent to those of foreign workers despite recent increas... Read More


Outstanding domestic tax arrears reach nearly Rs. 2.1 trillion at end of 2025 - IMF report

SriLanka, Nov. 1 -- A total of nearly Rs. 2.1 trillion in outstanding tax arrears had been recorded by the Inland Revenue Department (IRD) as of the end of 2025, according to a new report issued by th... Read More


Manipur: Protests across Naga areas demand end to SoO pact with Kuki militant groups

Imphal, Nov. 1 -- Coordinated mass rallies and sit-in protests erupted across the Naga-inhabited districts of Manipur on Saturday as demonstrators demanded the immediate termination of the Suspension ... Read More


Over 21,000 people affected by adverse weather across Sri Lanka

SriLanka, Nov. 1 -- A total of 21,356 individuals belonging to 5,800 families have been affected by the adverse weather conditions and Cyclonic Storm 'Arnab,' the Disaster Management Centre (DMC) repo... Read More


Sajith launches project to establish life-size statue of tusker 'Kawanthissa'

SriLanka, Nov. 1 -- Opposition Leader Sajith Premadasa has taken steps to create a life-size statue of the late tusker 'Kawanthissa' and launch a wildlife elephant conservation programme. The project... Read More